Erdosteine is an original mucoactive molecule, synthesized and developed by Edmond Pharma, and registered in many countries worldwide. There is evidence, both in preclinical and clinical studies, that ...

“Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data from more recent years are ...

GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...

Chronic obstructive pulmonary disease, or COPD, hasn’t seen any novel drugs in more than a decade. The FDA has approved a new inhalable medication whose innovation brings patients a dual approach to ...

Erdosteine is manufactured by Edmond Pharma (Milan, Italy) and commercialized in 42 countries in Europe and worldwide under different trade names (e.g., Erdotin ®, Erdomed ® and Mucotec ®). The drug ...